Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2003Cancer

Do we need HER‐2/neu testing for all patients with primary breast carcinoma?

View Full Paper
Ask AI
Bookmark
Share

Authors

STSusanne TaucherInnsbruck Medical UniversityMRMargaretha RudasComprehensive Cancer Center ViennaRMRobert M. MaderRoche (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Taucher et al. (2003) studied this question.

synapsesocial.com/papers/6a72f9d50659c579cd60dd11https://doi.org/10.1002/cncr.11828
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1C-erbB-2 Expression in Primary Breast Cancer1999 · 26 citations
  2. 2Clinical Laboratory Assays for HER-2/ <i>neu</i> Amplification and Overexpression2002 · 71 citations
  3. 3Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer1989 · 6,869 citations
  4. 4Testing for erbB-2 by Immunohistochemistry in Breast Cancer2000 · 62 citations